Trials / Conditions / Transthyretin Cardiac Amyloidosis

Transthyretin Cardiac Amyloidosis

10 registered clinical trials studyying Transthyretin Cardiac Amyloidosis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	EFICAC-TTR Trial: Exercise and Nutritional Supplementation in Transthyretin Cardiac Amyloidosis NCT07343999	Universidad de Burgos	N/A
Recruiting	Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis NCT06978660	Idoven 1903 S.L.	—
Recruiting	Exercise Training in Transthyretin Cardiac Amyloidosis NCT05797857	Brigham and Women's Hospital	N/A
Unknown	Prognostic Value of Echocardiographic Parameters Based on Machine Learning Approach NCT05772091	Pr. Nicolas GIRERD	—
Active Not Recruiting	Bronx Transthyretin Amyloid Cardiomyopathy Database NCT06257485	Montefiore Medical Center	—
Completed	Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis NCT04899180	Mayo Clinic	EARLY_Phase 1
Recruiting	Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post O NCT05489523	University of Texas Southwestern Medical Center	Phase 4
Unknown	Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis NCT06328075	Algalarrondo Vincent	—
Completed	Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in NCT05064839	Poitiers University Hospital	Phase 3
Completed	Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery NCT04276220	Steen Hvitfeldt Poulsen	N/A